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1. INTRODUCTION 
Ascorbic acid has long been recognized as an 
important vitamin [1], and has been shown to exist 
in high concentrations in the central nervous sys- 
tem of small animals and man. The regional dis- 
tribution of AA in rat [2] and human [3] brain has 
been reported. There appear to be homeostatic 
mechanisms for controlling AA levels, as well as 
an active uptake mechanism [4]. This, in addition 
to the many newly reported effects of AA on neu- 
ronal tissue, of which just a few are listed, suggests 
an important role(s) for this molecule in the func- 
tioning of mammalian brain [5-7]. 
Ascorbic acid oxidase (EC 1.10.3.3, AAO) has 
become a useful tool in the manipulation of [AA] 
in neuronal tissue preparations [8,9] for the pur- 
pose of gaining information on AA directly, as well 
as removing it as an interference in the electro- 
chemical determination of catecholamine neuro- 
transmitters, erotonin, and their key metabolites. 
With the intention of obtaining a form of this ex- 
tremely useful enzyme suitable for use in flowing 
stream analyses (for example, direct electrochem- 
ical analysis of neuronal tissue perfusates), we 
have immobilized AAO onto Sepharose 4B acti- 
vated by cyanogen bromide (CNBr). In [10] the en- 
zyme was immobilized in an enzyme electrode 
configuration; however, this method is unsuitable 
for the type of flowing stream applications inten- 
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ded. Using the method herein, the enzyme retains 
a high degree of catalytic activity upon immobil- 
ization and appears to be quite stable in the immo- 
bilized form. The following is an initial character- 
ization of the immobilized enzyme and a compari- 
son with the soluble form. 
2. MATERIALS AND METHODS 
AAO was obtained from Boehringer-Mannheim 
and used without further purification. Other chem- 
icals were obtained from the following commercial 
sources: Sepharose 4B, CNBr, bovine serum al- 
bumin and HEPES (Sigma Chemicals); EDTA 
and AA (Fisher Chemicals). Buffers and standard 
stock solutions were prepared as follows: 
Physiological buffe'r: 
20 mM HEPES, 5 mM KCI, 120 mM NaCI, 1 mM 
MgSO4, 2.5 mM CaC12, 10 mM glucose, pH ad- 
justed to 7.4 with NaOH. 
Assay buffe~: 
1 mg/ml bovine serum albumin (crystallized 
and lyophilized), 5 x 10 -4 M EDTA, 0.1 M 
(NaH2PO4, Na2HPO4) (pH 7.1) 
AA stock solution: 
10 or 20 mM AA, 0.1 M HCIO4, 5 x 10 -4 M 
EDTA (EDTA was present in order to reduce 
background oxidation of AA). 
2.1. Preparation of immobilized AA 0 
The procedure used for CNBr-activation of 
Sepharose was essentially that in [11]. After CNBr 
activation, 2-3 ml of settled gel was placed in a 
small culture tube ( -  1 cm x 6 cm). To this, 2 -  
3 ml 0.1 M NaHCO3 containing 2-3 mg AAO 
(weight of lyophilized powder) was added. The 
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tube was rotated slowly overnight at 4 ° C, then the 
AAO-Sepharose was rinsed with 200 ml H20 on a 
glass frit over vacuum. Finally, the resin was re- 
acted with 2 ml 1 M glycine in 0.1 M NaHCO3 
(pH8) for 2 h at room temperature with turning as 
before. After rinsing with 250 ml H20, the AAO-  
Sepharose was ready for use. A control prepara- 
tion of glycine-Sepharose was prepared by react- 
ing CNBr-activated Sepharose with 1 M glycine. 
To determine the extent of protein immobiliza- 
tion, A280 of the AAO solution prior to addition to 
the Sepharose was noted, as was A280 for the first 
7.5 ml of rinse following incubation. The dif- 
ference in absorbance (after dilution corrections) 
was asumed to be due to protein which was immo- 
bilized. 
2.2. Assay of AA O and immobilized AA O 
To assay for AAO activity, the change in [AA] 
was followed by chronoamperometry [12]. This 
method involves applying a fixed potential (in this 
case, 0.6 V vs and Ag/AgCI reference lectrode 
[Bioanalytical Systems]) to an inert solid electrode 
(carbon paste or glassy carbon [Bioanalytical Sys- 
tems]) and measuring the resultant anodic current 
due to the oxidation of AA after a fixed time 
(1 s). A PAR model 174 polarographic analyzer 
and Houston 2000 X--Y recorder with time base 
were used to generate and record the current-time 
curves .  
All assays were done in 10 ml physiological or 
assay buffer at ambient emperature. Chronoam- 
perometric measurements were generally taken 
every 30 s with - 5 s of stirring immediately fol- 
lowing each measurement. This stirring was neces- 
sary to disrupt the diffusion layer at the electrode 
surface in which AA had been depleted, and to 
keep the immobilized enzyme in suspension. Kine- 
tic parameters were determined by taking the slope 
of the [AA] vs time curve at various points, thus 
giving A#M/AT, or reaction velocity at varying 
[AA]. 
3. RESULTS AND DISCUSSION 
3.1. Comparison of the catalytic properties of AAO 
and AA O--Sepharose 
Fig.l shows a comparison between the catalytic 
activity of soluble AAO, AAO-Sepharose, and 
glycine-Sepharose. Clearly there is a catalytic 
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Fig.l. Comparison of the catalytic activity of -50 /~g 
soluble AAO (lyophilized powder,o), 0.05-0.1 ml 
AAO-Sepharose. (o) and 0.05-0.1 ml glycine- 
Sepharose (~). (-0 Additions to 20 /LM AA in l0 ml 
physiological buffer. Changes in [AA] were measured as 
in section 2. 
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Fig.2. pH profile of AAO-Sepharose activity. Aliquots 
of AA were added to 54 mg AAO-Sepharose, and ac- 
tivity was determined. Between the addition of each ali- 
quot, sufficient time was allowed for complete oxidation 
of AA, and the pH was adjusted with NaOH. A control 
run showed the catalytic activity of AAO--Sepharose 
was undiminished by repeated additions of AA. 
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activity which is not an artifactual property of 
AAO-Sepharose. To insure that AAO was indeed 
covalently bound to Sepharose, not just strongly 
adsorbed to the Sepharose, 2 additional control ex- 
periments were conducted. The first control ex- 
periment was to incubate the AAO overnight with 
unactivated Sepharose, and after rinsing as with 
the activated form, the gel was tested for catalytic 
activity; none was found. In the second control ex- 
periment, AAO-Sepharose was assayed for cataly- 
tic activity following repetitive rinsings on a glass 
frit over a vacuum. A sample of AAO-Sepharose 
was washed 4 times with 250 ml water. Between 
washes, an aliquot was removed and assayed for 
AAO activity. No decrease in activity resulted ur- 
ing this exhaustive washing process. 
3.2. Catalytic properties of AA 0 and AA O-  
Sepharose 
The pH profile of AAO-Sepharose activity was 
determined and the results are shown in fig.2. The 
pH optimum of 5.6 for AAO-Sepharose is the 
same as that reported for soluble enzyme [13]. Kin- 
values for AA as a substrate for the soluble and 
immobilized forms of AAO were also compared. 
There was a marked increase in the Km of AA for 
the immobilized enzyme as compared to that for 
the soluble enzyme (fig.3). This is consistent with a 
diffusional process being involved in the catalytic 
activity of the immobilized AAO [14]. We encoun- 
tered difficulty in obtaining reproducable Krn- 
values for the immobilized enzyme, probably be- 
cause the suspension of AAO-Sepharose and AA 
was stirred by hand following each chronoampero- 
metric measurement. A lack of a consistent s irring 
rate would have a marked effect on the diffusion 
of AA, presumably into recessed areas of the 
Sepharose beads which contain active enzyme. 
The Km-values determined for AA with the solu- 
ble AAO ranged from 100 - 350 #M, which is in 
fairly good agreement with apparent values calcu- 
lated from the literature of 250 ttM [15] and 
330/tM [16]. 
At 50 ~M AA, the specific activity of soluble 
AAO was determined to be 0.016 /~mol AA ox- 
idized, min -1 ./tg lyophilized AAO -1. On two 
consecutive runs, the specific activity of AAO- 
Sepharose was found to be 0.0038 and 0.0031 ~mol 
AA oxidized, min-I • bl, g AAO-Sepharose-l. 
Based on the amount of protein immobilized, 
which was determined tobe 60%, these specific ac- 
tivities indicate that the enzyme was immobilized 
with 24% and 19% apparent retention of activity, 
respectively. The immobilized enzyme when stored 
at 12°C retained catalytic activity for at least 
30 days. 
3.3. Catalytic specificity of AA O-Sepharose 
Soluble AAO will not oxidize dopamine (DA) or 
dihydroxyphenylacetate, a k y metabolite of DA 
[9]. Because these compounds, in addition to simi- 
lar catechols, will be present when the AAO- 
Sepharose is applied to brain tissue perfusates, the 
specificity of AAO for AA over catechols was re- 
affirmed. Physiological concentrations of DA and 
norepinephrine (NE) were not oxidized by the 
AAO-Sepharose (not shown), conforming the im- 
mobilized enzymes' high specificity for AA. 
3.4. Conclusion 
We demonstrate hat AAO can be immobilized 
with reasonable retention of activity onto Se- 
pharose using .CNBr activation. The pH optimum 
agrees with that for soluble AAO. The app. Km for 
AA is increased upon immobilization, consistent 
with a diffusional process being involved in the 
catalytic activity. The immobilized enzyme retains 
the specificity necessary for use in neurochemical 
investigations, and promises to be a useful tool in 
the study of neuronal tissue perfusates. 
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